DCDC2B
gene geneOn this page
Summary
DCDC2B (doublecortin domain containing 2B, HGNC:32576) is a protein-coding gene on chromosome 1p35.2, encoding Doublecortin domain-containing protein 2B (A2VCK2).
This gene encodes a member of the doublecortin family. The protein encoded by this gene contains two doublecortin domains. The doublecortin domain has been demonstrated to bind tubulin and enhance microtubule polymerization.
Source: NCBI Gene 149069 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 64 total
- MANE Select transcript:
NM_001099434
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:32576 |
| Approved symbol | DCDC2B |
| Name | doublecortin domain containing 2B |
| Location | 1p35.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000222046 |
| Ensembl biotype | protein_coding |
| Entrez | 149069 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 2 protein_coding, 1 retained_intron
ENST00000409358, ENST00000487056, ENST00000906474
RefSeq mRNA: 1 — MANE Select: NM_001099434
NM_001099434
CCDS: CCDS44100
Canonical transcript exons
ENST00000409358 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001579528 | 32215802 | 32216192 |
| ENSE00001583558 | 32212490 | 32212636 |
| ENSE00001587965 | 32209089 | 32209359 |
| ENSE00001588833 | 32212070 | 32212201 |
| ENSE00001589585 | 32211761 | 32211837 |
| ENSE00003610385 | 32212754 | 32212793 |
| ENSE00003632400 | 32211272 | 32211323 |
| ENSE00003663174 | 32214797 | 32214932 |
| ENSE00003686934 | 32215440 | 32215543 |
Expression profiles
Bgee: expression breadth ubiquitous, 157 present calls, max score 97.22.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0450 / max 18.5515, expressed in 17 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 1961 | 0.0450 | 17 |
Top tissues by expression
226 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right uterine tube | UBERON:0001302 | 97.22 | gold quality |
| bronchial epithelial cell | CL:0002328 | 90.84 | gold quality |
| bronchus | UBERON:0002185 | 90.14 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 89.12 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 86.94 | gold quality |
| kidney epithelium | UBERON:0004819 | 86.67 | gold quality |
| upper arm skin | UBERON:0004263 | 82.68 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 81.23 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 81.01 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 80.72 | silver quality |
| vena cava | UBERON:0004087 | 80.48 | silver quality |
| cerebellar vermis | UBERON:0004720 | 79.36 | silver quality |
| nasal cavity mucosa | UBERON:0001826 | 78.89 | gold quality |
| heart right ventricle | UBERON:0002080 | 78.67 | gold quality |
| vastus lateralis | UBERON:0001379 | 78.18 | gold quality |
| quadriceps femoris | UBERON:0001377 | 78.09 | gold quality |
| substantia nigra pars compacta | UBERON:0001965 | 78.05 | silver quality |
| lateral globus pallidus | UBERON:0002476 | 77.85 | silver quality |
| fallopian tube | UBERON:0003889 | 77.74 | gold quality |
| sperm | CL:0000019 | 77.67 | gold quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 77.65 | gold quality |
| subthalamic nucleus | UBERON:0001906 | 77.49 | silver quality |
| pharyngeal mucosa | UBERON:0000355 | 77.21 | gold quality |
| pons | UBERON:0000988 | 76.78 | silver quality |
| dorsal plus ventral thalamus | UBERON:0001897 | 76.54 | silver quality |
| mucosa of paranasal sinus | UBERON:0005030 | 76.48 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 76.14 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 76.03 | gold quality |
| cardia of stomach | UBERON:0001162 | 76.01 | silver quality |
| body of tongue | UBERON:0011876 | 75.93 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.87 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
15 targeting DCDC2B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6793-5P | 99.97 | 65.95 | 758 |
| HSA-MIR-8080 | 99.82 | 67.52 | 1342 |
| HSA-MIR-3202 | 99.66 | 67.70 | 2737 |
| HSA-MIR-5580-5P | 99.38 | 66.96 | 1139 |
| HSA-MIR-3191-5P | 99.24 | 66.52 | 1722 |
| HSA-MIR-3190-5P | 98.87 | 64.89 | 1345 |
| HSA-MIR-6829-5P | 98.86 | 65.12 | 1480 |
| HSA-MIR-3194-3P | 98.83 | 66.22 | 1167 |
| HSA-MIR-629-5P | 98.78 | 68.72 | 1032 |
| HSA-MIR-767-3P | 98.61 | 67.69 | 1192 |
| HSA-MIR-6847-5P | 97.93 | 66.74 | 1808 |
| HSA-MIR-4446-3P | 97.91 | 64.29 | 991 |
| HSA-MIR-630 | 97.50 | 66.38 | 921 |
| HSA-MIR-4435 | 95.90 | 65.47 | 1201 |
| HSA-MIR-3943 | 95.87 | 64.57 | 523 |
Cross-species orthologs
1 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Dcdc2b | ENSMUSG00000078552 |
Paralogs (2): DCDC2 (ENSG00000146038), DCDC2C (ENSG00000214866)
Protein
Protein identifiers
Doublecortin domain-containing protein 2B — A2VCK2 (reviewed: A2VCK2)
All UniProt accessions (1): A2VCK2
RefSeq proteins (1): NP_001092904* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR003533 | Doublecortin_dom | Domain |
| IPR036572 | Doublecortin_dom_sf | Homologous_superfamily |
Pfam: PF03607
UniProt features (6 total): domain 2, region of interest 2, chain 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A2VCK2-F1 | 68.12 | 0.12 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 36 (showing top):
GSE45365_NK_CELL_VS_CD8A_DC_DN, GOCC_MICROTUBULE_ORGANIZING_CENTER, chr1p35, DODD_NASOPHARYNGEAL_CARCINOMA_DN, GOCC_SUPRAMOLECULAR_COMPLEX, GOCC_POLYMERIC_CYTOSKELETAL_FIBER, GOCC_SUPRAMOLECULAR_POLYMER, ZNF30_TARGET_GENES, ZNF8_TARGET_GENES, GSE10239_NAIVE_VS_KLRG1INT_EFF_CD8_TCELL_UP, GSE10239_NAIVE_VS_KLRG1HIGH_EFF_CD8_TCELL_UP, GSE10239_NAIVE_VS_DAY4.5_EFF_CD8_TCELL_UP, MIR8080, GSE13229_IMM_VS_INTMATURE_NKCELL_UP, DESCARTES_MAIN_FETAL_CILIATED_EPITHELIAL_CELLS
GO Biological Process (1): intracellular signal transduction (GO:0035556)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (2): microtubule organizing center (GO:0005815), microtubule (GO:0005874)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| microtubule cytoskeleton | 2 |
| intracellular anatomical structure | 1 |
| signal transduction | 1 |
| binding | 1 |
| cellular anatomical structure | 1 |
| polymeric cytoskeletal fiber | 1 |
Protein interactions and networks
STRING
447 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| DCDC2B | DNAAF4 | Q8WXU2 | 637 |
| DCDC2B | KIAA0319 | Q5VV43 | 578 |
| DCDC2B | CCDC87 | Q9NVE4 | 561 |
| DCDC2B | KLHL23 | Q8NBE8 | 478 |
| DCDC2B | ATP2C2 | O75185 | 474 |
| DCDC2B | CMIP | Q8IY22 | 460 |
| DCDC2B | MFSD6L | Q8IWD5 | 444 |
| DCDC2B | NAGPA | Q9UK23 | 423 |
| DCDC2B | SLC15A5 | A6NIM6 | 414 |
| DCDC2B | SLC35F5 | Q8WV83 | 408 |
| DCDC2B | GNPTG | Q9UJJ9 | 397 |
| DCDC2B | FMR1 | Q06787 | 395 |
| DCDC2B | MIX23 | Q4VC31 | 389 |
| DCDC2B | POT1 | Q9NUX5 | 383 |
| DCDC2B | GNPTAB | Q3T906 | 378 |
IntAct
40 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| DCDC2B | FHL3 | psi-mi:“MI:0915”(physical association) | 0.720 |
| FHL3 | DCDC2B | psi-mi:“MI:0915”(physical association) | 0.720 |
| DCDC2B | MTUS2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT40 | DCDC2B | psi-mi:“MI:0915”(physical association) | 0.560 |
| BANP | DCDC2B | psi-mi:“MI:0915”(physical association) | 0.560 |
| RBPMS | DCDC2B | psi-mi:“MI:0915”(physical association) | 0.560 |
| MTUS2 | DCDC2B | psi-mi:“MI:0915”(physical association) | 0.560 |
| DCDC2B | BANP | psi-mi:“MI:0915”(physical association) | 0.560 |
| DCDC2B | RBPMS | psi-mi:“MI:0915”(physical association) | 0.560 |
| DCDC2B | CYSRT1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| DCDC2B | HSF2BP | psi-mi:“MI:0915”(physical association) | 0.560 |
| DCDC2B | KRTAP3-3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| DCDC2B | ZNF574 | psi-mi:“MI:0915”(physical association) | 0.560 |
| DCDC2B | FHL5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| DCDC2B | FRS3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| DCDC2B | HSPA8 | psi-mi:“MI:0914”(association) | 0.530 |
| DCDC2B | HMGN1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| DCDC2B | HSF2BP | psi-mi:“MI:0915”(physical association) | 0.000 |
| DCDC2B | CYSRT1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| DCDC2B | FHL3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| DCDC2B | KRTAP3-3 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (28): DCDC2B (Two-hybrid), DCDC2B (Two-hybrid), DCDC2B (Two-hybrid), DCDC2B (Two-hybrid), DCDC2B (Two-hybrid), FAT3 (Affinity Capture-MS), FAT4 (Affinity Capture-MS), PSMG4 (Affinity Capture-MS), FHL2 (Affinity Capture-MS), HSPA8 (Affinity Capture-MS), PSMG3 (Affinity Capture-MS), PCDH20 (Affinity Capture-MS), DCDC2B (Two-hybrid), DCDC2B (Two-hybrid), DCDC2B (Two-hybrid)
ESM2 similar proteins: A1L3T7, A2CI98, A2CJ06, A2VCK2, D3ZQL6, E1BBG2, M3WHG5, O15037, O43918, O70303, O75333, P48778, P59729, Q32PJ7, Q3KP66, Q3T191, Q5JYT7, Q5T124, Q5U4F0, Q5XIS1, Q6AXX1, Q6VYH9, Q7TSI1, Q80U38, Q8BGT6, Q8BHW9, Q8BWG4, Q8BWQ5, Q8BZ33, Q8BZW2, Q8C0J6, Q8C2K5, Q8CFK6, Q8IV53, Q8IY33, Q8IZW8, Q8K1S6, Q8K330, Q8N3F8, Q8TB24
Diamond homologs: A2VCK2, A8MYV0, D3ZR10, Q5DU00, Q9D1B8, Q9UHG0, Q9VUI3, P56715, P56716, Q550F6, Q69Z08, Q8CGM2, Q8IWN7, Q8MJ03, Q8MJ04, Q8MJ05, Q8MJ06, D2I3C6, O15075, O43602, O88809, Q5MPA9, Q6PGN3, Q8N568, Q95QC4, Q9JLM8, Q9ESI7, O00423, O95834, Q05BC3, Q26613, Q2TAF3, Q32P44, Q3UMY5, Q4V8C3, Q6DIP5, Q6P6T4, Q7TNG5, Q8VC03, Q9HC35
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
64 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 54 |
| Likely benign | 1 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1675 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:32209316:GGGCA:G | donor_gain | 1.0000 |
| 1:32209317:GGCAG:G | donor_gain | 1.0000 |
| 1:32209318:G:T | donor_gain | 1.0000 |
| 1:32209321:G:GG | donor_gain | 1.0000 |
| 1:32209360:G:GG | donor_gain | 1.0000 |
| 1:32211324:G:GG | donor_gain | 1.0000 |
| 1:32215435:TTTA:T | acceptor_loss | 1.0000 |
| 1:32215437:TA:T | acceptor_loss | 1.0000 |
| 1:32215438:A:AC | acceptor_loss | 1.0000 |
| 1:32215438:A:AG | acceptor_gain | 1.0000 |
| 1:32215439:G:GG | acceptor_gain | 1.0000 |
| 1:32209397:G:T | donor_gain | 0.9900 |
| 1:32211270:A:AG | acceptor_gain | 0.9900 |
| 1:32211271:G:GG | acceptor_gain | 0.9900 |
| 1:32211271:GCT:G | acceptor_gain | 0.9900 |
| 1:32212487:CAG:C | acceptor_loss | 0.9900 |
| 1:32212487:CAGA:C | acceptor_gain | 0.9900 |
| 1:32212488:A:AG | acceptor_gain | 0.9900 |
| 1:32212489:G:GG | acceptor_gain | 0.9900 |
| 1:32212489:GA:G | acceptor_gain | 0.9900 |
| 1:32212489:GACTC:G | acceptor_gain | 0.9900 |
| 1:32212569:GA:G | donor_gain | 0.9900 |
| 1:32215438:AG:A | acceptor_gain | 0.9900 |
| 1:32215439:GG:G | acceptor_gain | 0.9900 |
| 1:32215439:GGA:G | acceptor_gain | 0.9900 |
| 1:32215439:GGAGT:G | acceptor_gain | 0.9900 |
| 1:32209317:GGCA:G | donor_gain | 0.9800 |
| 1:32209318:GCAG:G | donor_gain | 0.9800 |
| 1:32209356:TCCA:T | donor_gain | 0.9800 |
| 1:32212069:GT:G | acceptor_gain | 0.9800 |
AlphaMissense
2223 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:32212074:T:C | F134L | 0.964 |
| 1:32212076:C:A | F134L | 0.964 |
| 1:32212076:C:G | F134L | 0.964 |
| 1:32212558:C:A | A199D | 0.953 |
| 1:32209190:T:C | F33L | 0.949 |
| 1:32209192:C:A | F33L | 0.949 |
| 1:32209192:C:G | F33L | 0.949 |
| 1:32209305:T:C | L71S | 0.945 |
| 1:32212072:T:A | V133E | 0.937 |
| 1:32212075:T:C | F134S | 0.935 |
| 1:32212575:T:C | F205L | 0.930 |
| 1:32212577:C:A | F205L | 0.930 |
| 1:32212577:C:G | F205L | 0.930 |
| 1:32209329:C:A | A79D | 0.924 |
| 1:32212082:T:A | N136K | 0.924 |
| 1:32212082:T:G | N136K | 0.924 |
| 1:32212081:A:T | N136I | 0.920 |
| 1:32209322:T:C | Y77H | 0.916 |
| 1:32212492:T:A | L177H | 0.912 |
| 1:32209209:T:C | F39S | 0.911 |
| 1:32209346:T:C | F85L | 0.909 |
| 1:32209348:C:A | F85L | 0.909 |
| 1:32209348:C:G | F85L | 0.909 |
| 1:32209323:A:C | Y77S | 0.903 |
| 1:32212555:T:A | V198E | 0.902 |
| 1:32212551:T:G | Y197D | 0.899 |
| 1:32209322:T:G | Y77D | 0.897 |
| 1:32209287:T:A | V65D | 0.894 |
| 1:32212084:G:T | G137V | 0.883 |
| 1:32209141:T:A | N16K | 0.873 |
dbSNP variants (sampled 300 via entrez): RS1000506821 (1:32208946 A>G), RS1000713531 (1:32216362 T>C), RS1000992739 (1:32209678 C>A,G), RS1001072443 (1:32213878 A>G), RS1001149018 (1:32211587 G>C), RS1001210066 (1:32211278 A>C,G), RS1002479267 (1:32215275 G>A,C), RS1002640719 (1:32211968 A>G,T), RS1003287179 (1:32213802 G>A), RS1003294999 (1:32212399 C>T), RS1003524935 (1:32212391 G>A,C), RS1003732344 (1:32207097 C>T), RS1004169343 (1:32215158 GC>G,GCC), RS1004403098 (1:32209966 G>A), RS1004502278 (1:32213785 C>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
9 total (human), top 9 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| butyraldehyde | increases expression | 1 |
| jinfukang | increases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Smoke | increases abundance, increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Cadmium Chloride | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.